/

FAGR.BR

FAGRONClosed

22.50+0.30 +1.35%EUR

Brussels · as of Oct 14, 11:35 ET · 15m delay

Open

22.20

Prev close

22.20

Day range

22.2022.80

52-week range

20.0025.30

Volume

106.63K1.13×

Mkt cap

1.65B

P/E ttm

18.00

Fwd P/E

13.73

EPS ttm

1.25

Div yield

1.80%

Earnings

Jul 30, 2026

From 52w high

−11.07%

Price Chart

Yahoo Finance · delayed

FAGR.BROct 13, 2026O 22.40H 22.95L 22.20C 22.20−0.20 (−0.89%)Vol 151.25K

SMA 5022.22
SMA 20022.91

1Y change +6.73% since Oct 14, 2025 close548 bars loadedTimes in Europe/BrusselsDraw from the left toolbar · click a drawing to edit · right-click for alerts and export

FAGR.BR FAGRON · Last Guard Finance

DES

Key Statistics

Yahoo Finance

Performance

1 week: −3.69%
1 month: +5.71%
3 months: −7.11%
6 months: −3.27%
Year to date: +4.23%
1 year: +5.97%

Valuation & ownership

Market cap: 1.65B
Enterprise value: 2.16B
P/E (ttm): 18.00
Forward P/E: 13.73
PEG ratio: 15.84
Price / book: 2.78
Price / sales (ttm): 1.61
EV / EBITDA: 12.38
EPS (ttm): 1.25
EPS (forward): 1.64
Beta (5y monthly): 0.35
Dividend yield: 1.80%
Payout ratio: 32.00%
Shares outstanding: 73.39M
Float: 65.85M
Short % of float: —
Short ratio (days): —
Held by insiders: 0.30%
Held by institutions: 71.88%
Avg volume (3m): 94.67K
50-day average: 22.22
200-day average: 22.91
52-week change: +5.97%
S&P 500 52-week: +15.71%

Technicals (daily)

RSI (14): 47.9
vs 50-day SMA: −0.09%
vs 200-day SMA: −3.09%
50 / 200-day trend: ▼ 50 below 200
MACD vs signal: ▼ below
ATR (14) % of price: 2.57%
Realised vol (20d, ann.): 31.3%
From 52-week high: −12.25%
From 52-week low: +11.00%

ANR

Analyst Consensus

6 analysts

Consensus

Strong buy

1.00 on a 1 (strong buy) – 5 (sell) scale

Mean target

29.00

+28.89% implied

Low 27.00Median 29.00High 31.00

Recommendation trend

Now6 / 0 / 0
1m ago6 / 0 / 0
2m ago

DES

About FAGRON

Yahoo Finance profile

Fagron NV, a pharmaceutical compounding company, delivers personalized pharmaceutical care to hospitals, pharmacies, clinics, patients, and worldwide. It operates through three segments: Essentials, Brands, and Compounding Services. The company's products include DiluCap, a line of excipients to compound every capsule formulation; DiluTab, for Cardiology and Primary care application; Imuno TF Complex helps in regulation of immune responses; Pigmerise, a natural phytocomplex for hypopigmentation disorders, such as vitiligo; Pentravan uses for avoiding first-pass metabolism and preventing gastrointestinal erosion; Nourisil MD, a first line therapy for prevention and treatment of scars ang keloids; Neogen, a line of hair care products; TrichoConcept used to treat alopecia; Fagron Advanced Derma for basic skincare, compound pharmaceutical treatment, and individualized dermatological care; SyrSpend SF that provides pharmaceutical stability, dosage consistency, and patient comfort; and Cleoderm, a topical cream used for the compounding of personalized dermatological treatments. It also offers education and professional development of prescribers, hospitals, and pharmacists through the Fagron Academy. The company was formerly known as Arseus NV and changed its name to Fagron NV in January 2015. Fagron NV was founded in 1990 and is based in Nazareth, Belgium.

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Employees: 4,880
Headquarters: Nazareth, Belgium
Website: fagron.com
Officers: Mr. Rafael Padilla CEO & Executive Director

SEAS

Seasonality · FAGR.BR

2007–2026 · monthly returns

Strongest month Apr +6.00%Weakest month Nov −3.52%Averages use completed years only. Past seasonality doesn't predict future returns.

Year	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec	Year
2026	4.0	2.7	-5.1	11.1	0.4	0.0	-3.7	-4.1	4.5	-3.2			+5.6%
2025	14.1	-2.9	2.0	8.2	5.6	3.7	-3.1	-4.6	-4.7	4.1	3.4	0.0	+27.1%
2024	0.4	7.8	-1.7	3.3	3.2	-3.2	4.5	0.6	-2.9	-0.3	0.8	-10.3	+0.9%
2023	2.3	12.7	2.9	7.2	-0.3	-8.3	4.9	1.7	-2.1	2.9	4.8	-4.4	+25.2%
2022	3.0	2.0	6.2	7.9	-8.0	-5.9	-3.5	-14.1	-1.6	0.1	-0.6	6.0	−10.3%
2021	7.4	-3.1	-4.2	-1.4	-0.3	1.2	-7.1	1.4	-4.7	-11.4	-11.7	12.0	−22.1%
2020	8.1	-8.9	-5.6	14.5	4.5	-13.0	1.4	0.2	13.3	-11.5	1.9	-2.2	−1.7%
2019	11.4	2.4	-1.7	10.4	-3.2	4.3	-15.9	8.7	-0.3	4.6	8.9	4.3	+35.4%
2018	-0.4	16.0	-4.0	13.0	-1.5	4.0	8.1	2.9	2.3	-13.6	4.8	-5.2	+25.1%
2017	-7.3	13.7	17.4	0.8	-5.7	-5.6	7.1	10.4	-3.3	-9.6	-1.4	4.0	+17.5%
2016	-3.3	-19.1	5.0	9.7	25.4	7.5	-9.6	10.7	21.9	-6.9	-2.0	10.1	+48.6%
2015	4.2	-8.7	9.7	8.6	4.6	-10.1	15.4	-44.6	-28.2	31.4	-55.2	-29.5	−79.7%
2014	-4.1	29.3	14.0	4.6	-2.2	4.5	-3.7	2.9	-7.4	-16.9	3.6	5.0	+25.6%
2013	11.3	15.5	2.4	-2.2	1.1	0.1	-3.0	9.7	-2.5	8.4	5.1	15.8	+78.3%
2012	-3.4	11.5	3.3	4.3	15.2	-5.8	-5.0	-2.4	12.0	0.2	-0.2	7.5	+40.5%
2011	-0.4	2.0	4.2	2.6	-2.1	-6.2	-0.3	-0.7	-7.8	11.0	-11.3	8.1	−3.1%
2010	7.0	-0.2	5.4	0.0	-2.2	5.0	-0.2	0.9	7.0	2.9	-3.8	14.9	+41.4%
2009	-4.0	-4.2	-2.3	16.5	10.7	-9.9	16.8	2.9	-1.9	6.6	-5.0	3.2	+28.8%
2008	-5.4	5.5	-1.0	0.1	2.0	-13.4	-4.6	5.8	-7.5	-13.2	-4.6	0.0	−32.4%
2007											-4.4	0.8	−3.6%

FAGR.BR

Price Chart

Keyboard shortcuts & functions

Anywhere

Command line

Charts (click the chart first)

Function codes

FAGR.BR

Price Chart

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About FAGRON

Seasonality · FAGR.BR

Insider Activity · FAGR.BR

Congress Trades · FAGR.BR

Investors Holding FAGR.BR

Investors Holding FAGR.BR

Congress Trades · FAGR.BR

Insider Activity · FAGR.BR

Seasonality · FAGR.BR

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About FAGRON

Financial Snapshot

Earnings & Dividends

News